论文部分内容阅读
目的观察依达拉奉联合奥扎格雷钠治疗急性脑梗死的临床疗效。方法将200例急性脑梗死患者随机分为二组,治疗组100例,常规治疗基础上应用依达拉奉30 mg(国药集团国瑞药业有限公司生产)加0.9%氯化钠溶液100 ml静脉滴注,2次/d,奥扎格雷钠250 ml(含0.9%氯化钠溶液250 ml,奥扎格雷钠80 mg,石家庄四药有限公司生产)静脉滴注,2次/d。对照组100例,常规治疗基础上应用奥扎格雷钠250 ml(含0.9%氯化钠溶液250ml,奥扎格雷钠80 mg)静脉滴注,2次/d。2周后进行疗效评定。结果治疗组有效率95%,对照组有效率83%。结论依达拉奉联合奥扎格雷钠治疗急性脑梗死疗效肯定,能有效改善急性脑梗死患者的神经功能缺失。
Objective To observe the clinical efficacy of edaravone combined with ozagrel sodium in the treatment of acute cerebral infarction. Methods 200 patients with acute cerebral infarction were randomly divided into two groups, the treatment group of 100 patients on the basis of routine treatment with edaravone 30 mg (Guoyu Guorui Pharmaceutical Co., Ltd.) plus 0.9% sodium chloride solution 100 ml Intravenous infusion, 2 times / d, ozagrel sodium 250 ml (containing 0.9% sodium chloride solution 250 ml, ozagrel sodium 80 mg, Shijiazhuang four drugs Limited) intravenous infusion, 2 times / d. The control group of 100 cases, based on conventional treatment with Ozagrel 250ml (containing 0.9% sodium chloride solution 250ml, ozagrel sodium 80mg) intravenously, 2 times / d. 2 weeks after the curative effect evaluation. Results The effective rate of the treatment group was 95% and that of the control group was 83%. Conclusion Edaravone combined with ozagrel sodium in the treatment of acute cerebral infarction positive effect, can effectively improve the patients with acute cerebral infarction neurological deficit.